This was one of my first investments as a young naive investor and seeing the unexpected results with the disheartening crash is quite tough on all of us.
This might be me being naive, but I would say this is a perfect buying opportunity to lower your average purchase price and get set for the next rise. As highlighted earlier, the issues with the drug can be fixed (usually) and retrialled and of course there are two other chances for PAR to shine. I still have faith in this company and see this seller's overreaction as the perfect buying opportunity.
As always, this is just my opinion; DYOR.
Ann: Hay Fever Trial Update, page-7
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
0.060(13.0%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 56.0¢ | 40.0¢ | $4.475M | 8.971M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12150 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 39994 | 1 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
